Beating Cardiac Bodies

Beating Cardiac Bodies - A Complete Workflow

DownloaD cardiac tissue report

Stem cell derived cardiomyocytes gain more and more attention in the field of cardiovascular research, disease modeling and drug development.

The CERO 3D Incubator & Bioreactor platform allows the workflow with stem cell expansion in homogeneous aggregates followed by direct induction into a high number of beating cardiac bodies. The expansion of pluripotent stem cells and subsequent cardiac induction/differentiation in CERO 3D results in a much higher cell quality, homogeneity, integrity and yield compared to traditional orbital shakers. 


CERO 3D versus Orbital shaker – differentiation of murine embryonic stem cell derived cardiomyocytes 3, 8 and 13 days after cardiac induction.

  • Homogeneous 3D aggregates in suspension
  • Expansion and differentiation in the same CEROtube
  • Easy to handle & standardize
  • Highest yield
  • No substrate required
  • More relevance for drug treatments
  • More relevance for disease modeling



​

Purified and homogeneous cardiac bodies generated in CERO 3D Incubator & Bioreactor are a perfect tool for disease modeling and drug discovery. The pure cardiomyocytes can also be used in 2D downstream monolayer applications.

Invite our experts and lift your research to the next stage with a demo 3D CERO Incubator and Bioreactor from OLS

​Join OLS and make your research reliable with our 3D CERO Incubator and Bioreactor with your lab-services as results.

​​​​​​​​​​Request CERO 3D Demo